LEP and ovarian carcinoma: Leptin was noted to reduce the proportion of cells in the G2/M phase in HO8910PM and OV-MZ-15 ovarian cancer lines cells treated with paclitaxel, suggesting that leptin may reduce the sensitivity of ovarian cancer cells to paclitaxel’s effect on microtubules [2].